share_log

Investors in Acadia Healthcare Company (NASDAQ:ACHC) Have Seen Splendid Returns of 209% Over the Past Five Years

Investors in Acadia Healthcare Company (NASDAQ:ACHC) Have Seen Splendid Returns of 209% Over the Past Five Years

在過去五年中,阿卡迪亞醫療保健公司(納斯達克股票代碼:ACHC)的投資者獲得了209%的豐厚回報
Simply Wall St ·  01/19 05:41

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, you can make far more than 100% on a really good stock. For example, the Acadia Healthcare Company, Inc. (NASDAQ:ACHC) share price has soared 209% in the last half decade. Most would be very happy with that. On top of that, the share price is up 13% in about a quarter. But this could be related to the strong market, which is up 13% in the last three months.

在購買公司股票(假設沒有槓桿作用)之後,最糟糕的結果是你損失了所有投入的資金。但好的一面是,購買一隻非常好的股票,您可以賺取超過100%的收入。例如,阿卡迪亞醫療保健公司(納斯達克股票代碼:ACHC)的股價在過去五年中飆升了209%。大多數人會對此感到非常滿意。最重要的是,股價在大約一個季度內上漲了13%。但這可能與強勁的市場有關,市場在過去三個月中上漲了13%。

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

考慮到這一點,值得一看公司的基本面是否是長期業績的驅動力,或者是否存在一些差異。

See our latest analysis for Acadia Healthcare Company

查看我們對阿卡迪亞醫療公司的最新分析

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。

Over half a decade, Acadia Healthcare Company managed to grow its earnings per share at 38% a year. We do note that extraordinary items have impacted its earnings history. This EPS growth is higher than the 25% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock.

在過去的五年中,阿卡迪亞醫療公司設法將其每股收益增長到每年38%。我們確實注意到,非同尋常的項目影響了其收益記錄。每股收益的增長高於股價25%的平均年增長率。因此,人們可以得出結論,整個市場對該股變得更加謹慎。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何隨着時間的推移而變化的(點擊圖片發現確切的值)。

earnings-per-share-growth
NasdaqGS:ACHC Earnings Per Share Growth January 19th 2024
納斯達克GS:ACHC每股收益增長 2024年1月19日

It might be well worthwhile taking a look at our free report on Acadia Healthcare Company's earnings, revenue and cash flow.

可能值得一看我們關於阿卡迪亞醫療公司收益、收入和現金流的免費報告。

A Different Perspective

不同的視角

Acadia Healthcare Company shareholders are up 0.5% for the year. Unfortunately this falls short of the market return. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 25% over five years. It's quite possible the business continues to execute with prowess, even as the share price gains are slowing. It's always interesting to track share price performance over the longer term. But to understand Acadia Healthcare Company better, we need to consider many other factors. Even so, be aware that Acadia Healthcare Company is showing 2 warning signs in our investment analysis , you should know about...

阿卡迪亞醫療公司的股東今年上漲了0.5%。不幸的是,這沒有達到市場回報率。這可能是一個好兆頭,表明該公司的長期業績記錄甚至更好,在五年內爲股東提供了25%的年度股東總回報率。儘管股價上漲放緩,但該業務很有可能繼續表現出色。長期跟蹤股價表現總是很有意思的。但是,要更好地了解阿卡迪亞醫療保健公司,我們需要考慮許多其他因素。即便如此,請注意,阿卡迪亞醫療保健公司在我們的投資分析中顯示了兩個警告信號,你應該知道...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,通過尋找其他地方,你可能會找到一筆不錯的投資。因此,請看一下我們預計收益將增加的這份免費公司名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論